A Mechanistic Evaluation of the Interactions Between Thermoceptive and Pruriceptive Sensory Processing

Sponsor
Aalborg University (Other)
Overall Status
Completed
CT.gov ID
NCT03576053
Collaborator
(none)
59
1
3
13.9
4.2

Study Details

Study Description

Brief Summary

The purpose of this human experimental study is to evaluate the pattern of itch intensity over time in response to strong, short-term heat stimulation in two different models of histamine and cowhage-induced itch. Moreover, the purpose is to evaluate the effect of mild pre-heating of the skin in human experimental models of histamine, cowhage and serotonin. Finally, we want to investigate the effect of short-term intense heat stimulation on previously anesthetized skin.

Condition or Disease Intervention/Treatment Phase
  • Drug: Lidocaine
  • Other: Histamine
  • Other: Cowhage
  • Other: Heat stimulation
  • Other: Pre-heating
  • Other: Serotonin
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Masking Description:
Only the third sub-study is conducted in a double-blind manner.
Primary Purpose:
Basic Science
Official Title:
En Mekanistisk undersøgelse af Interaktioner Imellem Det Thermoceptive og Det Pruriceptive Sensoriske System
Actual Study Start Date :
Jul 1, 2018
Actual Primary Completion Date :
Jul 31, 2019
Actual Study Completion Date :
Aug 28, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Histamine+cowhage+heat

Other: Histamine
Skin Prick Test with Histamine

Other: Cowhage
Manually skin insertion of cowhage spicules

Other: Heat stimulation
Short heat stimulation

Experimental: Histamine+cowhage+serotonin+pre-heating

Other: Histamine
Skin Prick Test with Histamine

Other: Cowhage
Manually skin insertion of cowhage spicules

Other: Pre-heating
Mild skin pre-heating

Other: Serotonin
Serotonin electrophoresis

Placebo Comparator: lidocaine and saline+heat

Drug: Lidocaine
Lidocaine intradermal injection

Other: Heat stimulation
Short heat stimulation

Outcome Measures

Primary Outcome Measures

  1. eVAS Itch [10 minutes]

    Electronic Visual Analog Scale for itch sensation. 0-100 scale, it measures the self-estimated itch the subject experience on a scale where 0 correspond to "No itch" and 100 "Worst itch imaginable".

  2. Skin temperature [5 seconds]

    Infrared skin thermometer

  3. eVAS Pain [10 minutes]

    Electronic Visual Analog Scale for pain sensation. 0-100 scale, it measures the self-estimated pain the subject experience on a scale where 0 correspond to "No pain" and 100 "Worst pain imaginable".

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy men and women

  • Age 18-60 years

  • Able to speak and understand English

Exclusion Criteria:
  • Suffering from chronic disease

  • Pregnancy or lactation

  • Prior experience of adverse effects from anaesthetic, specifically Lidocaine

  • Drug addiction defined as the use of cannabis, opioids or other drugs - 5 -

  • Previous neurologic, musculoskeletal or mental illnesses

  • Lack of ability to cooperate

  • Current use of medications that may affect the trial

  • Active skin diseases

  • Active participation in other experiments currently ongoing or within the last 14 days

  • Tattoos on volar forearms that will interfere with local skin measurements

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aalborg University Aalborg Nordjylland Denmark 9220

Sponsors and Collaborators

  • Aalborg University

Investigators

  • Principal Investigator: Daniele Riccio, MSc, Aalborg University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Daniele Riccio, Principal investigator, Aalborg University
ClinicalTrials.gov Identifier:
NCT03576053
Other Study ID Numbers:
  • N-20180035
First Posted:
Jul 3, 2018
Last Update Posted:
Jul 8, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2020